Proteon Therapeutics Inc. Garners $12,000,000 Series B Financing Round

  • Feed Type
  • Date
    5/28/2009
  • Company Name
    Proteon Therapeutics Inc.
  • Mailing Address
    200 West Street Waltham, MA 02451
  • Company Description
    Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
  • Website
    http://www.proteontherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Devon Park Bioventures

Trending on Xconomy